|
Published by: HBS Consulting
Published: Aug. 1, 2003 - 146 Pages
Table of Contents
1. Executive Summary
2. Introduction
3. The Current Situation - Public
Environment & Politics in Europe
- 3.1 Public Awareness……
- 3.1.1 Who is the public
- 3.1.2 How to reach the end user
- 3.2 Patent situation…
- 3.3 Standardisation & Quality Measures
- 3.3.1 Harmonization of Standards
- 3.3.2 Molecular Diagnostics - quick and
impeccable?
- 3.3.3 Standardized tests - two sites of a
- coin
3.3.4 Who defines the standard?
- 3.4 Reimbursement & Prices
4. The Market of Molecular Diagnostics
- 4.1 Overview
- 4.2 Nucleic acid purification……
- 4.2.1 The Market
- 4.2.2 Driver & Restraints
- 4.2.3 Forecasting
- 4.3 Nucleic acid Amplification
- 4.3.1 The Market
- Amplification in infectious disease
- Amplification in blood screening
- Amplification in genetic testing
- 4.3.2 Amplification methods
- Polymerase Chain Reaction
- non-PCR amplification techniques
- Automation of Amplification Methods
- 4.3.4 Driver and Restraints
- 4.3.5 Forecasting
5. NAT Applications
- 5.1. Blood testing and infectious diseases
- 5.1.1 The Market
- 5.1.2 Market Influences and Forecast
- 5.2. Cancer…
- 5.2.1 The Market
- 5.2.2 Market Influences and Forecast
- 5.3 SNPs - advantage of being a little different
- 5.3.1 The Market
- 5.3.2 Market Influences and Forecast
- 5.4 Food diagnostics
- 5.4.1 The Market
- 5.4.2 Strategies and Forecasting
6. Trends in Molecular Diagnostics
- 6.1 Pharmacogenomics
- 6.1.1 The Market
- 6.1.2 Market Influences and Forecast
- 6.2 DNA Microarrays
- 6.2.1 The Technique
- 6.2.2 The Market
- Identification of sequence
- SNPs
- Determination gen expression level
- 6.2.3 Emerging Markets of DNA Arrays
- Pharmacogenomics
- Cancer
- Microbiology
- Human leukocyte antigen typing
- Neonatal screening
- 6.2.4 Drivers and restraints
- 6.2.5 Forecast
7. Asia - Market of Chance
- 7.1 The Market overview
- 7.2 Selected Asian markets…
- 7.2.1 The Elite
- Japan
- Australia and New Zealand
- 7.2.2 Developing Markets
- China
- India
- 7.3 Outlook…
8. Companies
- 8.1. Merger & Acquisitions…
- 8.1.1 The Situation
- 8.1.2 Merger
- Advantages
- Disadvantages
- Examples
- 8.1.3 Alternatives
- Strategic allies
- Collaborations
- Examples
- 8.2 Company profiles………………
AbstractMolecular diagnostic technologies offer the potential for
moving from diagnostics to prognostics. But what is
“molecular diagnostics? By definition, it includes all tests
and methods to identify a disease or the predisposition
for a disease analyzing DNA- or RNA of an organism.
Get Full Details About This Report >>
|
